Clinical trials
Tolerance clinical trials
Below are recruiting tolerance clinical trials, each written for real people, not researchers. We’re tracking 948 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07254481RecruitingPhase 1
Safety study of VB19055 in healthy volunteers
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
HangzhouAges 18–50 - NCT07258745RecruitingPhase 1
Comparing a risankizumab biosimilar to Skyrizi in healthy adults
This study tests a new biosimilar medicine (CKD-704) to see how it compares to the approved Skyrizi treatments for healthy adults. It checks how the medicine moves through the body, its safety, and how the immune system responds.
Warsaw, WarszawaAges 18–55 - NCT07260305RecruitingPhase 1
Study of KGX101 alone or with Envafolimab for advanced solid tumors
This trial tests a new drug combination (KGX101 with envafolimab) for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if these drugs are safe and could help shrink tumors.
Beijing, Beijing MunicipalityAges 18–75 - NCT07262281RecruitingPhase 1
Safety study of HY6725 in healthy adults
This trial tests a new drug called HY6725 in healthy volunteers to see if it is safe and how the body processes it. It may help pave the way for future treatments.
MelbourneAges 18–55 - NCT07263139RecruitingPhase 2
Testing AGP100 for CPVT heart condition
This trial tests a new drug called AGP100 for people with CPVT, a genetic heart condition that causes dangerous heartbeats during exercise. The goal is to see if AGP100 can safely reduce these abnormal heart rhythms.
OsloAges 18–75 - NCT07264569RecruitingPhase 1/Phase 2
Testing a new drug for lung cancer that has spread to the brain or spinal fluid
This trial tests a new drug called BioTTT001 for people with non-small cell lung cancer (NSCLC) that has spread to the fluid around the brain or the lining of the brain (leptomeninges). The goal is to see if the drug is safe and can help control the cancer.
Zhengzhou, HenanAges 18–70 - NCT07267130RecruitingPhase 1
Safety study of TQC3302 inhaler in healthy adults
This trial tests a new inhaled medication (TQC3302) in healthy adults to see if it is safe and how the body processes it. It is a first-in-human study for a potential treatment for lung conditions.
Beijing, Beijing MunicipalityAges 18–55 - NCT07281703RecruitingPhase 1
Safety study of HY8931 in healthy adults
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
BrisbaneAges 18–45 - NCT07283263RecruitingPhase 1
Safety study of new drug BMS-986521 in healthy volunteers
This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.
Anaheim, CaliforniaAges 18–80 - NCT07286656RecruitingPhase 1
A study of GensSci098 for Graves' disease
This study tests a new investigational drug called GensSci098 for people with Graves' disease who have not taken antithyroid medication recently. It aims to see if the drug can help manage thyroid hormone levels.
Shenyang, LiaoningAges 18 years+ - NCT07286747RecruitingPhase 2
Nicotinic Acid for Reversing Prediabetes
This trial tests whether a controlled-release form of nicotinic acid (a type of vitamin B3) can help people with prediabetes get their blood sugar back to normal. It also looks at how the treatment affects liver health.
KielAges 18–79 - NCT07287397RecruitingPhase 1/Phase 2
Testing VTx-002 for safety in ALS patients
This trial tests a new drug called VTx-002 to see if it is safe and tolerable for people with ALS. You may be able to join if you have had symptoms for less than 18 months and have a caregiver who can help.
Phoenix, ArizonaAges 18 years+ - NCT07288021RecruitingPhase 4
Topical anesthesia for balloon catheter insertion
This trial tests whether applying a numbing cream to the cervix before inserting a balloon catheter makes the procedure less painful for women being induced into labor. If you are scheduled for labor induction with a balloon, this study may help reduce your discomfort.
HaifaAges 18 years+ - NCT07290283RecruitingPhase 1
Testing safety of AZD3974 in healthy volunteers
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
Glendale, CaliforniaAges 18–55 - NCT07291323RecruitingEarly Phase 1
Safety study of JANX011 in healthy adults
This trial tests a new drug called JANX011 in healthy adults to see if it is safe and well tolerated. It is a first step before testing in patients.
Adelaide, South AustraliaAges 18–65 - NCT07295600Recruiting
Fruits and vegetables for blood sugar control in type 2 diabetes
This study tests whether meals made with local fruits and vegetables can help control blood sugar in people with type 2 diabetes. You will eat special test meals and have your blood sugar checked afterward.
WakisoAges 30–60 - NCT07298343RecruitingPhase 2
Testing ZED1227 for non-responsive celiac disease
This trial tests a new medicine, ZED1227, for people with celiac disease who still have symptoms despite eating gluten-free. The goal is to see if it helps reduce those symptoms.
MainzAges 18–80 - NCT07299955RecruitingPhase 1
Testing a new Herceptin shot in healthy men
This trial tests a new version of the breast cancer drug Herceptin (called Bmab3000) given as a single shot under the skin. It looks at how the drug moves through the body, its safety, and how the immune system responds, in healthy volunteers.
Christchurch, Main Building: 264 Antigua Street,Ages 18–65 - NCT07302269RecruitingPhase 1
Safety study of VV261 tablets in healthy Chinese volunteers
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
Hefei, AnhuiAges 18–45 - NCT07303790RecruitingEarly Phase 1
Study of GC012F for people with multiple sclerosis
This early phase trial tests a new treatment called GC012F for people with multiple sclerosis. It aims to see how safe and tolerable it is, and may offer a new option for those whose current treatments are not working well enough.
Hubei, HubeiAges 18 years+ - NCT07304089RecruitingPhase 2
Study of VIM0423 for people with dystonia
This trial tests an experimental drug called VIM0423 for people with isolated dystonia (a condition causing muscle spasms in multiple body parts). It aims to see if the drug can improve symptoms safely.
Birmingham, AlabamaAges 18–65 - NCT07307274RecruitingPhase 1
Safety study of SYNT-101 in healthy and overweight adults
This trial tests a new medicine called SYNT-101 in healthy and overweight adults to see if it is safe and how the body processes it. It may help researchers learn if this drug could be used for weight-related conditions in the future.
Bayswater, VictoriaAges 18–55 - NCT07308769RecruitingPhase 4
Iron supplements for women with low iron
This trial compares two types of iron supplements (Sucrosomial Iron and Ferric Maltol) to see which works better and causes fewer side effects in women with low iron levels. It may help if you have mild to moderate anemia and are not taking other iron supplements.
BarcelonaAges 18 years+ - NCT07312864RecruitingPhase 1/Phase 2
New bioartificial liver for liver failure and small-for-size syndrome
This study tests a new bioartificial liver made from special cells to support people with severe liver problems, including liver failure or when the liver is too small after surgery. It aims to see if it is safe and can help the liver recover.
BeijingAges Any age
Hear when a new Tolerance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tolerance?
- Yes. Clin2 currently lists 948 recruiting tolerance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tolerance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tolerance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.